EP1575552A4 - Metallhaltige materialien,zusammensetzungen und verfahren - Google Patents

Metallhaltige materialien,zusammensetzungen und verfahren

Info

Publication number
EP1575552A4
EP1575552A4 EP03781362A EP03781362A EP1575552A4 EP 1575552 A4 EP1575552 A4 EP 1575552A4 EP 03781362 A EP03781362 A EP 03781362A EP 03781362 A EP03781362 A EP 03781362A EP 1575552 A4 EP1575552 A4 EP 1575552A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
metal
containing materials
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03781362A
Other languages
English (en)
French (fr)
Other versions
EP1575552A2 (de
Inventor
Robert E Burrell
John B Wright
Kan Lam
Hua Qing Yin
Antony G Naylor
Peter H Moxham
Paul Schechter
Scott H Gillis
James Alexander Robert Stiles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew Overseas Ltd
Original Assignee
Smith and Nephew Overseas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/277,362 external-priority patent/US20030194444A1/en
Priority claimed from US10/277,358 external-priority patent/US20030185901A1/en
Priority claimed from US10/277,356 external-priority patent/US20030170314A1/en
Priority claimed from US10/277,320 external-priority patent/US20030206966A1/en
Priority claimed from US10/277,298 external-priority patent/US6989157B2/en
Priority claimed from US10/277,673 external-priority patent/US20030180379A1/en
Application filed by Smith and Nephew Overseas Ltd filed Critical Smith and Nephew Overseas Ltd
Publication of EP1575552A2 publication Critical patent/EP1575552A2/de
Publication of EP1575552A4 publication Critical patent/EP1575552A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP03781362A 2002-10-22 2003-10-22 Metallhaltige materialien,zusammensetzungen und verfahren Withdrawn EP1575552A4 (de)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US277356 1981-06-25
US277362 1988-11-29
US277673 1999-03-26
US277298 1999-03-26
US10/277,362 US20030194444A1 (en) 2000-07-27 2002-10-22 Methods of treating skin and integument conditions
US10/277,358 US20030185901A1 (en) 2000-07-27 2002-10-22 Methods of treating conditions with a metal-containing material
US277358 2002-10-22
US10/277,356 US20030170314A1 (en) 2000-07-27 2002-10-22 Compositions of metal-containing compounds
US10/277,320 US20030206966A1 (en) 2000-07-27 2002-10-22 Methods of inducing apoptosis and modulating metalloproteinases
US10/277,298 US6989157B2 (en) 2000-07-27 2002-10-22 Dry powders of metal-containing compounds
US10/277,673 US20030180379A1 (en) 2000-07-27 2002-10-22 Solutions and aerosols of metal-containing compounds
US364983 2003-02-12
US10/364,983 US7078060B2 (en) 2000-07-27 2003-02-12 Solutions and aerosols of metal-containing compounds
PCT/US2003/033446 WO2004037187A2 (en) 2002-10-22 2003-10-22 Metal-containing materials, compositions and methods
US277320 2006-03-23

Publications (2)

Publication Number Publication Date
EP1575552A2 EP1575552A2 (de) 2005-09-21
EP1575552A4 true EP1575552A4 (de) 2011-05-25

Family

ID=32180857

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03781362A Withdrawn EP1575552A4 (de) 2002-10-22 2003-10-22 Metallhaltige materialien,zusammensetzungen und verfahren

Country Status (4)

Country Link
EP (1) EP1575552A4 (de)
AU (1) AU2003287183A1 (de)
CA (1) CA2500836A1 (de)
WO (1) WO2004037187A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2460585A1 (en) 2003-05-16 2004-11-16 Exciton Technologies Inc. Deposition products, composite materials and processes for the production thereof
RU2306141C1 (ru) * 2005-12-28 2007-09-20 Институт энергетических проблем химической физики Российской академии наук (ИНЭП ХФ РАН) Препарат, ускоряющий ранозаживление
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU980695A1 (ru) * 1981-03-13 1982-12-15 Московский научно-исследовательский институт туберкулеза Способ лечени кавернозного туберкулеза легких
WO2002085385A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200723A1 (de) * 1972-01-07 1973-07-19 Fresenius Chem Pharm Ind Salbe zur behandlung von epithelschaeden der haut
US5374432A (en) * 1989-07-28 1994-12-20 The Trustees Of Columbia University Of The City Of New York Topical anti-infective ointment containing silver or silver salts and antibiotics
US6258385B1 (en) * 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU980695A1 (ru) * 1981-03-13 1982-12-15 Московский научно-исследовательский институт туберкулеза Способ лечени кавернозного туберкулеза легких
WO2002085385A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 198341, Derwent World Patents Index; AN 1983-787749, XP002632519 *

Also Published As

Publication number Publication date
AU2003287183A1 (en) 2004-05-13
EP1575552A2 (de) 2005-09-21
WO2004037187A2 (en) 2004-05-06
CA2500836A1 (en) 2004-05-06
WO2004037187A8 (en) 2004-07-22
AU2003287183A8 (en) 2004-05-13
WO2004037187A3 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
AU2003262747A8 (en) Compounds, compositions, and methods
EP1503993A4 (de) Verbindungen, verfahren und zusammensetzungen
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
AU2003270015A8 (en) Compounds, compositions, and methods
EP1646382A4 (de) Verbindungen, zusammensetzungen und verfahren
AU2003299612A8 (en) Compounds, compositions and methods
EP1692112A4 (de) Verbindungen, zusammensetzungen und verfahren
EP1542699A4 (de) Verbindungen, zusammensetzungen und diese verwendende verfahren
IL164581A0 (en) Compounds, compositions and methods
AU2003277079A8 (en) Compounds, compositions, and methods
EP1594849A4 (de) Verbindungen, zusammensetzungen und verfahren
EP1496893A4 (de) Neuroprotektionsverfahren, zusammensetzungen und screening-verfahren dafür
GB0202059D0 (en) Chemical compositions and methods
AU2003290507A8 (en) Compounds, compositions and methods
AU2003297079A8 (en) Anti-filming materials, compositions and methods
IL167936A0 (en) Compounds, compositions,and methods
EP1675834A4 (de) Verbindungen, zusammensetzungen und verfahren
EP1680420A4 (de) Verbindungen, zusammensetzungen und verfahren
EP1620092A4 (de) Verbindungen, zusammensetzungen und verfahren
AU2003267169A8 (en) Compounds, compositions and methods
AU2003300031A8 (en) Compounds, compositions, and methods
EP1706111A4 (de) Verbindungen, zusammensetzungen und verfahren
AU2003287183A8 (en) Metal-containing materials, compositions and methods
EP1622878A4 (de) Verbindungen, zusammensetzungen und verfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050523

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIN1 Information on inventor provided before grant (corrected)

Inventor name: STILES, JAMES ALEXANDER ROBERT

Inventor name: GILLIS, SCOTT, H

Inventor name: SCHECHTER, PAUL

Inventor name: MOXHAM, PETER, H.

Inventor name: NAYLOR, ANTONY, G.

Inventor name: YIN, HUA QING

Inventor name: LAM, KAN

Inventor name: WRIGHT, JOHN, B.

Inventor name: BURRELL, ROBERT, E.

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SMITH & NEPHEW (OVERSEAS) LIMITED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 11/00 20060101ALI20110414BHEP

Ipc: A61P 17/00 20060101ALI20110414BHEP

Ipc: A61K 33/28 20060101ALI20110414BHEP

Ipc: A61K 31/28 20060101ALI20110414BHEP

Ipc: A61K 9/14 20060101ALI20110414BHEP

Ipc: A61K 9/00 20060101AFI20050608BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20110421

17Q First examination report despatched

Effective date: 20111221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120703